Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis.

Xie D, Gore C, Zhou J, Pong RC, Zhang H, Yu L, Vessella RL, Min W, Hsieh JT.

Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):19878-83. doi: 10.1073/pnas.0908458106. Epub 2009 Nov 10.

2.

WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis.

Nguyen DX, Chiang AC, Zhang XH, Kim JY, Kris MG, Ladanyi M, Gerald WL, Massagué J.

Cell. 2009 Jul 10;138(1):51-62. doi: 10.1016/j.cell.2009.04.030. Epub 2009 Jul 2.

3.

Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease.

Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA.

J Clin Invest. 2009 Jun;119(6):1438-49. doi: 10.1172/JCI38019. Epub 2009 Jun 1. Review.

4.

AIP1 functions as an endogenous inhibitor of VEGFR2-mediated signaling and inflammatory angiogenesis in mice.

Zhang H, He Y, Dai S, Xu Z, Luo Y, Wan T, Luo D, Jones D, Tang S, Chen H, Sessa WC, Min W.

J Clin Invest. 2008 Dec;118(12):3904-16. doi: 10.1172/JCI36168. Epub 2008 Nov 3.

5.

Protein phosphatase 2A regulatory subunits and cancer.

Eichhorn PJ, Creyghton MP, Bernards R.

Biochim Biophys Acta. 2009 Jan;1795(1):1-15. doi: 10.1016/j.bbcan.2008.05.005. Epub 2008 Jun 3. Review.

PMID:
18588945
6.

Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.

Yang J, Weinberg RA.

Dev Cell. 2008 Jun;14(6):818-29. doi: 10.1016/j.devcel.2008.05.009. Review.

7.

Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways.

Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, Weinberg RA.

Cancer Res. 2008 May 15;68(10):3645-54. doi: 10.1158/0008-5472.CAN-07-2938.

8.

AIP1 recruits phosphatase PP2A to ASK1 in tumor necrosis factor-induced ASK1-JNK activation.

Min W, Lin Y, Tang S, Yu L, Zhang H, Wan T, Luhn T, Fu H, Chen H.

Circ Res. 2008 Apr 11;102(7):840-8. doi: 10.1161/CIRCRESAHA.107.168153. Epub 2008 Feb 21.

9.

Cancer statistics, 2008.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ.

CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96. doi: 10.3322/CA.2007.0010. Epub 2008 Feb 20.

10.

Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP.

Duggan D, Zheng SL, Knowlton M, Benitez D, Dimitrov L, Wiklund F, Robbins C, Isaacs SD, Cheng Y, Li G, Sun J, Chang BL, Marovich L, Wiley KE, Bälter K, Stattin P, Adami HO, Gielzak M, Yan G, Sauvageot J, Liu W, Kim JW, Bleecker ER, Meyers DA, Trock BJ, Partin AW, Walsh PC, Isaacs WB, Grönberg H, Xu J, Carpten JD.

J Natl Cancer Inst. 2007 Dec 19;99(24):1836-44. Epub 2007 Dec 11.

PMID:
18073375
11.

Inactivation of Apc in the mouse prostate causes prostate carcinoma.

Bruxvoort KJ, Charbonneau HM, Giambernardi TA, Goolsby JC, Qian CN, Zylstra CR, Robinson DR, Roy-Burman P, Shaw AK, Buckner-Berghuis BD, Sigler RE, Resau JH, Sullivan R, Bushman W, Williams BO.

Cancer Res. 2007 Mar 15;67(6):2490-6.

12.

Differential expression of hDAB2IPA and hDAB2IPB in normal tissues and promoter methylation of hDAB2IPA in hepatocellular carcinoma.

Qiu GH, Xie H, Wheelhouse N, Harrison D, Chen GG, Salto-Tellez M, Lai P, Ross JA, Hooi SC.

J Hepatol. 2007 Apr;46(4):655-63. Epub 2006 Dec 12.

PMID:
17258345
13.

The epithelial-mesenchymal transition: new insights in signaling, development, and disease.

Lee JM, Dedhar S, Kalluri R, Thompson EW.

J Cell Biol. 2006 Mar 27;172(7):973-81. Review.

14.

Complex networks orchestrate epithelial-mesenchymal transitions.

Thiery JP, Sleeman JP.

Nat Rev Mol Cell Biol. 2006 Feb;7(2):131-42. Review.

PMID:
16493418
15.

Non-traditional roles for the Adenomatous Polyposis Coli (APC) tumor suppressor protein.

Hanson CA, Miller JR.

Gene. 2005 Nov 21;361:1-12. Epub 2005 Sep 26. Review.

PMID:
16185824
16.

N-cadherin switching occurs in high Gleason grade prostate cancer.

Jaggi M, Nazemi T, Abrahams NA, Baker JJ, Galich A, Smith LM, Balaji KC.

Prostate. 2006 Feb 1;66(2):193-9.

PMID:
16173043
17.

Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin.

Ding Q, Xia W, Liu JC, Yang JY, Lee DF, Xia J, Bartholomeusz G, Li Y, Pan Y, Li Z, Bargou RC, Qin J, Lai CC, Tsai FJ, Tsai CH, Hung MC.

Mol Cell. 2005 Jul 22;19(2):159-70.

18.
19.

Wnt signalling and prostate cancer.

Yardy GW, Brewster SF.

Prostate Cancer Prostatic Dis. 2005;8(2):119-26. Review.

PMID:
15809669
20.

Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis.

McManus EJ, Sakamoto K, Armit LJ, Ronaldson L, Shpiro N, Marquez R, Alessi DR.

EMBO J. 2005 Apr 20;24(8):1571-83. Epub 2005 Mar 24.

Supplemental Content

Support Center